The novel approach of the medication represents a exciting advance in the management of the condition. Distinct from existing drugs, tirzepatide affects multiple pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatide-peptide086030.dgbloggers.com/42506274/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment